Evolent Health Statistics

Total Valuation

Evolent Health has a market cap or net worth of $439.71 million. The enterprise value is $1.41 billion.

Market Cap	439.71M
Enterprise Value	1.41B

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Evolent Health has 111.60 million shares outstanding. The number of shares has increased by 0.65% in one year.

Current Share Class	111.60M
Shares Outstanding	111.60M
Shares Change (YoY)	+0.65%
Shares Change (QoQ)	-1.57%
Owned by Insiders (%)	1.76%
Owned by Institutions (%)	103.69%
Float	86.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	16.62
PS Ratio	0.22
Forward PS	0.19
PB Ratio	0.52
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.68
EV / EBITDA	17.60
EV / EBIT	303.86
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.33, with a Debt / Equity ratio of 1.29.

Current Ratio	1.33
Quick Ratio	1.17
Debt / Equity	1.29
Debt / EBITDA	12.78
Debt / FCF	n/a
Interest Coverage	0.10

Financial Efficiency

Return on equity (ROE) is -12.40% and return on invested capital (ROIC) is 0.15%.

Return on Equity (ROE)	-12.40%
Return on Assets (ROA)	0.12%
Return on Invested Capital (ROIC)	0.15%
Return on Capital Employed (ROCE)	0.23%
Revenue Per Employee	$456,456
Profits Per Employee	-$40,197
Employee Count	4,500
Asset Turnover	0.83
Inventory Turnover	n/a

Taxes

In the past 12 months, Evolent Health has paid $430,000 in taxes.

Income Tax	430,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.77% in the last 52 weeks. The beta is 0.27, so Evolent Health's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-65.77%
50-Day Moving Average	6.27
200-Day Moving Average	8.67
Relative Strength Index (RSI)	30.93
Average Volume (20 Days)	5,628,150

Short Selling Information

The latest short interest is 18.76 million, so 16.81% of the outstanding shares have been sold short.

Short Interest	18.76M
Short Previous Month	17.62M
Short % of Shares Out	16.81%
Short % of Float	21.71%
Short Ratio (days to cover)	4.75

Income Statement

In the last 12 months, Evolent Health had revenue of $2.05 billion and -$180.89 million in losses. Loss per share was -$1.57.

Revenue	2.05B
Gross Profit	378.34M
Operating Income	4.63M
Pretax Income	-127.75M
Net Income	-180.89M
EBITDA	79.84M
EBIT	4.63M
Loss Per Share	-$1.57

Full Income Statement

Balance Sheet

The company has $116.65 million in cash and $1.08 billion in debt, giving a net cash position of -$965.67 million or -$8.65 per share.

Cash & Cash Equivalents	116.65M
Total Debt	1.08B
Net Cash	-965.67M
Net Cash Per Share	-$8.65
Equity (Book Value)	842.23M
Book Value Per Share	7.55
Working Capital	140.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.19 million and capital expenditures -$79.80 million, giving a free cash flow of -$115.99 million.

Operating Cash Flow	-36.19M
Capital Expenditures	-79.80M
Free Cash Flow	-115.99M
FCF Per Share	-$1.04

Full Cash Flow Statement

Margins

Gross margin is 18.42%, with operating and profit margins of 0.23% and -6.24%.

Gross Margin	18.42%
Operating Margin	0.23%
Pretax Margin	-6.22%
Profit Margin	-6.24%
EBITDA Margin	3.89%
EBIT Margin	0.23%
FCF Margin	n/a

Dividends & Yields

Evolent Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.65%
Shareholder Yield	-0.65%
Earnings Yield	-41.14%
FCF Yield	-26.38%

Dividend Details

Analyst Forecast

The average price target for Evolent Health is $12.25, which is 210.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.25
Price Target Difference	210.91%
Analyst Consensus	Strong Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	8.41%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Evolent Health has an Altman Z-Score of 0.91 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.91
Piotroski F-Score	4